Bernd Kasper
Mannheim University Medical Center · University of Heidelberg Mannheim University Medical Center Interdisciplinary Tumor Center, Sarcoma Unit · University Medical Centre Mannheim
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Bernd Kasper as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:23 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT03785964 · Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany · completed · Desmoid Tumor, Aggressive Fibromatosis · principal investigator
- N/ANCT03022448 · Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)GWT-TUD GmbH · completed · Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma · principal investigator
- Ph2NCT01692496 · Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical TrialGrupo Espanol de Investigacion en Sarcomas · completed · Advanced and / or Metastatic Liposarcoma · principal investigator
- Ph1NCT01426633 · Combination Therapy of Gemcitabine and Trabectedin in L-sarcomasHeidelberg University · completed · Leiomyosarcoma, Liposarcoma · principal investigator
- Ph2NCT01137916 · Study to Evaluate Imatinib in Desmoid TumorsHeidelberg University · completed · Aggressive Fibromatosis, Desmoid Tumor · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:23 UTC. The ranking covers the 200 most relevant of 40 PubMed records, and a shared surname and initials can bring in a namesake. All 40 on PubMed
- Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.N Engl J Med · 2023229 citationsRCR 21.4
- Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial.Epilepsia · 2012195 citationsRCR 7.5
- The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.Eur J Cancer · 2019170 citationsRCR 8.0
- Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis.Acta Oncol · 2017161 citationsRCR 6.7
- 99 citationsRCR 3.9
- 98 citationsRCR 2.9
- 77 citationsRCR 3.4
- 72 citationsRCR 2.6
- Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.Eur J Cancer · 202170 citationsRCR 3.7
- 50 citationsRCR 2.2